Syra Health (SYRA) CEO Gregory Receives 368,458-Unit Award

What Happened Alexander Gregory R., CEO of Syra Health Corp (SYRA), was granted 368,458 performance stock units (PSUs) on 2026-08-31. The award is reported as a derivative acquisition at $0.00 per unit (no cash paid). This Form 4 is an amended filing dated 2026-09-28 that reports the grant.

Key Details

• Transaction date: 2026-08-31 (Amended Form 4 filed 2026-09-28).
• Award: 368,458 performance stock units, reported at $0.00 (derivative award).
• Vesting: 20% of the PSUs vest one year after grant; the remainder vest only upon achievement of specified company financial metrics (footnote F1).
• Shares owned after transaction: not specified in the supplied filing.
• Filing status: This is an amended Form 4; the filing amends prior reporting (original filing details not provided).

Context This was an equity compensation award, not an open-market purchase or sale. PSUs typically convert to common shares only after vesting conditions are met, so the award’s ultimate value depends on time and the company meeting its financial targets. Amended filings often correct or clarify prior reports; investors should treat contingent awards differently from immediate purchases when gauging insider sentiment.